Bhavana Pothuri MD
Gynecologic Oncology
Professor, Obstetrics & Gynecology, New York University School of Medicine Director, Gynecologic Oncology Clinical Trials
Join to View Full Profile
160 E 34th StNew York, NY 10016
Phone+1 212-731-6455
Fax+1 212-731-5600
Dr. Pothuri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bhavana Pothuri is an Obstetrics and Gynecology specialist with a subspecialty in Gynecologic Oncology, based in New York, NY. She completed her medical education at Sidney Kimmel Medical College, followed by a residency in Obstetrics and Gynecology at Main Line Health System/Lankenau Medical Center, and a fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Pothuri is a professor at New York University School of Medicine and has extensive experience in ovarian neoplasms, fallopian tube carcinoma, and robotic gynecologic surgery. Her research has led to numerous publications on topics such as ovarian cancer treatments and clinical trial diversity. She has participated in clinical trials focusing on various gynecologic cancers and has been recognized as a top doctor in the New York Metro Area. Dr. Pothuri is a Fellow of the American Congress of Obstetricians and Gynecologists.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2003
Main Line Health System/Lankenau Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
NY State Medical License 2000 - 2027
PA State Medical License 1996 - 2002
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- NY Magazine Top Doctors 2018
- Top Doctors: New York Metro Area Castle Connolly, 2014-2018
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer Start of enrollment: 2010 Jun 01
- Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors Start of enrollment: 2016 Mar 07
- Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2017 Jun 23
- Join now to see all
Publications & Presentations
PubMed
- Treatment preferences of patients with recurrent or metastatic cervical cancer: a discrete choice experiment in the US.Premal H Thaker, Hui Lu, Yitong J Zhang, Myrto Trapali, Paul Swinburn
Gynecologic Oncology Reports. 2025-10-01 - Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210...Koji Matsuo, Danielle M Enserro, Jason D Wright, Lynda D Roman, Matthew A Powell
Gynecologic Oncology. 2025-09-03 - Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: strategies for prevention and treatment.Michelle D S Lightfoot, Maria M Rubinstein, Bradley J Monk, Ramez N Eskander, Kathleen Lutz
International Journal of Gynecological Cancer. 2025-09-01
Authored Content
- Articles & IssuesDecember 2018
Press Mentions
What Can We Do About Health Disparities in the Diagnosis and Treatment of Endometrial Cancer?August 27th, 2024- Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial CancerMay 11th, 2023
- Remove Fallopian Tubes to Prevent Ovarian Cancer, Research Group SaysFebruary 3rd, 2023
- Join now to see all
Committees
- Co-Chair, SGO COVID Task Force 2020 - Present
- Co-Chair, SGO COVID Task Force 2020 - Present
- Co-Chair, SGO COVID Task Force 2020 - Present
- Vice Chair, SGO Clinical Practice Committee 2018 - Present
- Secretary, NYU Langone Health Faculty Council 2018 - Present
- Co-Chair, SGO COVID Task Force 2020 - 2020
- Co-Chair, SGO COVID Task Force 2020 - 2020
- Co-Chair, SGO COVID Task Force 2020 - 2020
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- NY Obstetrical SocietyMember
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
